PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,337.00
Bid: 1,348.00
Ask: 1,350.00
Change: -15.00 (-1.11%)
Spread: 2.00 (0.148%)
Open: 1,353.00
High: 1,376.00
Low: 1,337.00
Prev. Close: 1,352.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Records for FTSE and CAC but US PPI hits New York

Thu, 16th Feb 2023 16:55

(Alliance News) - Blue-chip benchmarks in London and Paris hit record highs on Thursday, with the FTSE 100 managing to cling to its daily gain, despite some weakness following US producer price data.

Another red-hot US inflationary reading saw the FTSE 100 slip into negative territory. It climbed back into the green as the afternoon progressed, however, but closed off session high.

"It's been a day of two halves for European markets today, with both the FTSE 100 and CAC 40 making new record highs this morning, before slipping back from those peaks during the afternoon session," CMC Markets analyst Michael Hewson commented.

"The catalyst for the pullback was a US PPI report, which punched a hole in the speed of the disinflation narrative that has driven this week's stock market gains. It was a timely reminder to markets that while inflation may have peaked, the move lower in prices isn't going to be a straight line, and that there are likely to be many twists and turns on the way."

The FTSE 100 index ended up 14.70 points, or 0.2%, at 8,012.53. It struck a record high of 8,047.06 points earlier on Thursday.

The FTSE 250 closed 15.82 points, or 0.1%, lower at 20,156.77. The AIM All-Share edged up by just under 0.10 of a point, closing at 869.59.

The Cboe UK 100 closed up 0.1% at 801.94, the Cboe UK 250, however, fell 0.1% to 17,553.06. The Cboe Small Companies lost 0.2% to 14,012.77.

In European equities on Thursday, the CAC 40 in Paris surged 0.9%, it had hit a record high in late-morning trade. The DAX 40 in Frankfurt closed up 0.2%.

On a monthly basis, the US producer price index for final demand increased 0.7% in January, reversing from a 0.2% decline in December.

This came above expectations, according to FXStreet. Markets had expected the producer price index to increase 0.4% in January.

Excluding food, energy and trade services, the index for final demand rose 0.6% in January. The US Bureau said this was the index's largest advance since March 2022.

On an annual basis, the index for final demand rose 6.0% in January, slowing from a 6.5% increase in December. Markets had expected producer price inflation to cool to 5.4%.

Stocks in New York were lower around the time of the closing bell in London, spooked by the inflation data.

The Dow Jones Industrial Average, S&P 500 and Nasdaq Composite each fell 0.7%.

The pound was quoted at USD1.2004 at late Thursday in London, largely unchanged from USD1.2007 at the close on Wednesday. The euro stood at USD1.0674 Thursday, up slightly against USD1.0669 at the London equities close on Wednesday. Against the yen, the dollar was trading at JPY134.08, lower compared to JPY134.32.

In London, British Gas owner Centrica climbed 5.7%.

It reported a swing to a statutory loss in 2022 on re-measurement and higher operating costs, but adjusted profit tripled as revenue surged 84%.

The Windsor, England-based firm revealed a pretax loss of GBP240 million in 2022, compared to a profit of GBP954 million in 2021.

The swing to a loss was on re-measurements after taxation, Centrica said, largely reflecting the revaluation of UK energy supply hedging positions due to wholesale gas and power price falls towards the end of the year. The cost for re-measurement and settlement of derivative energy contracts ballooned to GBP8.48 billion in 2022 from GBP434 million in 2021.

However, adjusted operating profit tripled to GBP3.31 billion from GBP948 million.

Centrica added it intends to extend its existing GBP250 million buyback programme, announced in November, by an additional GBP300 million. This would result in Centrica buying back 10% of its share capital, the power utility said.

Standard Chartered rose 4.1%. It reported a pretax profit of USD4.29 billion in 2022, up 28% from USD3.35 billion in 2021, as interest income jumped by nearly 50% to USD15.25 billion from USD10.25 billion.

Profit fell short of consensus, however. It also announced a USD1 billion share buyback.

Among FTSE 250 stocks, Indivior tumbled 14%. The pharmaceutical company reported a swing to loss as it counts the cost of litigation provisions.

It posted a pretax loss of USD95 million in 2022 from a profit of USD190 million in 2021, despite a jump by 14% in net revenue to USD901 million from USD791 million.

Indivior booked a USD290 million exceptional provision in 2022, as it navigates initial mediation sessions in late January regarding legacy civil multi-district antitrust litigation.

Sausage casings maker Devro received an increased and "final" takeover offer from suitor Saria worth GBP564 million.

The Glasgow, Scotland-based firm deems the bid "fair and reasonable". Devro shares ended 6.7% higher, giving it a market capitalisation of GBP547.6 million.

On AIM, Jaywing tumbled 35%. The advertising and marketing agency expects an annual outturn below market expectations.

Its pipeline of new business remains "encouraging" but warned it has seen a softening in demand over the past two months.

As a result, significant project revenue previously expected to start in the fourth quarter of its financial year is now unlikely to begin by the March 31 year-end.

Full year revenue is now expected between GBP22.0 million and GBP22.5 million, compared to GBP23.3 million in financial 2022, with adjusted earnings before interest, tax, depreciation and amortisation ahead of last year but below market expectations.

Brent oil was quoted at USD85.13 a barrel in London on Thursday, up from USD84.07 late Wednesday. Gold was quoted at USD1,835.31 an ounce, higher against USD1,832.19.

Friday's economic calendar has a UK retail sales reading and German producer price index data at 0700 GMT.

The local corporate calendar has annual results from lender NatWest and property investment firm Segro.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more
22 Feb 2024 08:26

Indivior planning to move primary listing to US, shares surge

(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
20 Dec 2023 15:05

London close: Stocks rise as UK inflation slows further

(Sharecast News) - London's stock markets saw a notable upswing on Wednesday, driven by encouraging data revealing a greater-than-anticipated slowdown in UK inflation for November.

Read more
20 Dec 2023 11:56

LONDON MARKET MIDDAY: Stocks sparkle thanks to UK inflation data

(Alliance News) - Stock prices in London were higher at midday Wednesday, as investors felt the festive cheer thanks to cooler-than-expected inflation data for the UK.

Read more
20 Dec 2023 10:59

IN BRIEF: Indivior agrees settlement with Actavis over patent dispute

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Says its subsidiaries Indivior Inc and Indivior UK Ltd has agreed on a settlement deal with Actavis Laboratories UT Inc, a subsidiary of Teva Pharmaceuticals, resolving patent disputes of Actavis's abbreviated new drug application for generic buprenorphine and naloxone sublingual film. Says it has granted Actavis a license to US patent no.11,135,216, allowing it to launch general film products in the US from January 31 2025, unless unexpired patent claims are found to be invalid.

Read more
20 Dec 2023 08:48

LONDON MARKET OPEN: Stocks feeling festive on UK, US rate cut hopes

(Alliance News) - Stock in London enjoyed a broad-based rally at Wednesday's open, as a surprise UK inflation print boosted risk sentiment, with investors pinning their hopes on UK and US interest rate cuts next year.

Read more
20 Dec 2023 07:26

Indivior strikes agreement with Actavis over patent dispute

(Sharecast News) - Indivior announced significant agreement in its ongoing patent dispute with Actavis Laboratories UT, a subsidiary of Teva Pharmaceuticals, on Wednesday.

Read more
5 Dec 2023 15:38

Indivior and Reckitt land legal boost in UK Suboxone claim

(Alliance News) - Indivior PLC and one-time parent Reckitt Benckiser Group PLC were handed a legal victory on Tuesday after the High Court of Justice of England & Wales dismissed a lawsuit related to alleged false marketing of an opioid addiction treatment.

Read more
24 Nov 2023 09:23

LONDON BROKER RATINGS: Investors told to 'sell' Sage and Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
20 Nov 2023 14:59

London close: Stocks mixed ahead of Autumn Statement

(Sharecast News) - London's stock markets saw a mixed performance at the close of trading on Monday, with Ashtead and Compass among the leading losers.

Read more
17 Nov 2023 12:15

Indivior announces $100m share buyback

(Sharecast News) - Pharma group Indivior has announced a $100m share buyback to reduce its issued shared capital and return cash to shareholders.

Read more
17 Nov 2023 12:08

UPDATE: Indivior plans up to USD100 million share buyback programme

(Alliance News) - Indivior PLC on Friday announced a new share buyback programme, as it hailed its outlook for medium-term profitable growth.

Read more
17 Nov 2023 09:46

Indivior to keep Scopia's Jerome Lande on board as agreement extended

(Alliance News) - Indivior PLC on Friday said it changed its existing relationship with Scopia Capital Management LP to keep Scopia representative Jerome Lande on the Indivior board.

Read more
17 Nov 2023 07:56

Indivior extends deal with investor Scopia to keep boardmember Jerome Lande

(Sharecast News) - Pharma group Indivior has extended its deal with shareholder Scopia Capital Management that will see the latter's representative Jerome Lande stay on the board until the end of next year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.